Biomarkers of Inflammation and Remodelling in Cystic Fibrosis

ISSN： 2212-7070

Source： Clinical Immunology, Endocrine & Metabolic Drugs, Vol.3, Iss.2, 2017-08, pp. : 92-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Airway Inflammation in Cystic Fibrosis in Children: Past, Present, and Future

By Pressler Tacjana

Pediatric Drugs, Vol. 13, Iss. 3, 2011-06 ,pp. : 141-147

Adis International

Access to resources Recommend Favorite

Inhaled Hypertonic Saline as a Therapeutic Strategy to Dampen Inflammation in Cystic Fibrosis

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 3, Iss. 2, 2017-08 ,pp. : 109-116

Bentham Science Publishers

Access to resources Recommend Favorite

Macrophage Dysfunctions in Cystic Fibrosis Pulmonary Disease: Implications in Inflammation and Chronic Infections

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 3, Iss. 2, 2017-08 ,pp. : 82-91

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Disposition in Cystic Fibrosis

By Rey E. Tréluyer J-M. Pons G.

Clinical Pharmacokinetics, Vol. 35, Iss. 4, 1998-10 ,pp. : 313-329

Adis International

Access to resources Recommend Favorite

Nebulized Antibiotics in Cystic Fibrosis

By Sermetgaudelus I.

Pediatric Drugs, Vol. 4, Iss. 7, 2002-01 ,pp. : 455-467

Adis International

Access to resources Recommend Favorite